{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:40:00Z","timestamp":1790005200811,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejphar.2023.175759","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T20:59:55Z","timestamp":1682715595000},"page":"175759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Ergothioneine improves myocardial remodeling and heart function after acute myocardial infarction via S-glutathionylation through the NF-\u0138B dependent Wnt5a-sFlt-1 pathway"],"prefix":"10.1016","volume":"950","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7283-1618","authenticated-orcid":false,"given":"Rui","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DongCheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175759_bib1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.175759_bib2","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2023.175759_bib3","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1017\/jns.2020.44","article-title":"Is ergothioneine a 'longevity vitamin' limited in the American diet?","volume":"9","author":"Beelman","year":"2020","journal-title":"J. Nutr. Sci."},{"key":"10.1016\/j.ejphar.2023.175759_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1095\/biolreprod59.6.1540","article-title":"A vascular endothelial growth factor antagonist is produced by the human","volume":"59","author":"Clark","year":"1998","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ejphar.2023.175759_bib5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.amjmed.2014.04.015","article-title":"The epidemic of the 20(th) century: coronary heart disease","volume":"127","author":"Dalen","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2023.175759_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.micro.55.1.333","article-title":"Novel thiols of prokaryotes","volume":"55","author":"Fahey","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejphar.2023.175759_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/00365513.2016.1190863","article-title":"Sflt-1 in heart failure: relation with disease severity and biomarkers","volume":"76","author":"Gruson","year":"2016","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.ejphar.2023.175759_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002115","article-title":"Elevated soluble fms-like tyrosine kinase-1 and placental-like growth factor levels are associated with development and mortality risk in heart failure","volume":"9","author":"Hammadah","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejphar.2023.175759_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/mend.13.4.0265","article-title":"Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity","volume":"13","author":"He","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2023.175759_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2576823","article-title":"The antiaging activity of ergothioneine in UVA-irradiated human dermal fibroblasts via the inhibition of the AP-1 pathway and the activation of Nrf2-mediated antioxidant genes","volume":"2020","author":"Hseu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.175759_bib11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/eurheartj\/ehz182","article-title":"Managing acute myocardial infarction in China","volume":"40","author":"Hu","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2023.175759_bib12","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.jcin.2015.08.018","article-title":"Outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention receiving an oral anticoagulant and dual antiplatelet therapy: a comparison of clopidogrel versus prasugrel from the TRANSLATE-ACS study","volume":"8","author":"Jackson","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ejphar.2023.175759_bib13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/ATVBAHA.110.215897","article-title":"Elevated soluble fms-like tyrosine kinase-1 levels in acute coronary occlusion","volume":"31","author":"Kapur","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2023.175759_bib14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/ijmm_00000190","article-title":"Transcriptional mechanisms of WNT5A based on NF-kappaB, Hedgehog, TGFbeta, and Notch signaling cascades","volume":"23","author":"Katoh","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2023.175759_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1996.1355","article-title":"Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR","volume":"226","author":"Kendall","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2023.175759_bib16","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.1000181","article-title":"Wnt5a induces endothelial inflammation via beta-catenin-independent signaling","volume":"185","author":"Kim","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.175759_bib17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4070\/kcj.2012.42.7.464","article-title":"Serial plasma levels of angiogenic factors in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"42","author":"Kim","year":"2012","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.ejphar.2023.175759_bib18","article-title":"Effect of ergothioneine on 7-ketocholesterol-induced endothelial injury","author":"Koh","year":"2020","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.ejphar.2023.175759_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1189\/jlb.0910505","article-title":"Adenosine modifies the balance between membrane and soluble forms of Flt-1","volume":"90","author":"Leonard","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2023.175759_bib20","doi-asserted-by":"crossref","first-page":"14377","DOI":"10.1074\/jbc.M109.075242","article-title":"S-glutathionylation regulates inflammatory activities of S100A9","volume":"285","author":"Lim","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175759_bib21","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1203\/01.PDR.0000159567.85157.B7","article-title":"Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia","volume":"57","author":"Maynard","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejphar.2023.175759_bib22","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.1074\/jbc.M113.517219","article-title":"Glutaredoxin-1 up-regulation induces soluble vascular endothelial growth factor receptor 1, attenuating post-ischemia limb revascularization","volume":"289","author":"Murdoch","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175759_bib23","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1161\/CIRCULATIONAHA.109.916346","article-title":"Monocytes: protagonists of infarct inflammation and repair after myocardial infarction","volume":"121","author":"Nahrendorf","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.175759_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034434","article-title":"Modulation of Wnt5a expression by periodontopathic bacteria","volume":"7","author":"Nanbara","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175759_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.amjcard.2009.07.016","article-title":"Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction","volume":"104","author":"Onoue","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175759_bib26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejmech.2016.05.039","article-title":"Contemporary developments in the discovery of selective factor Xa inhibitors: a review","volume":"121","author":"Patel","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.175759_bib27","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/cdd.2009.163","article-title":"The unusual amino acid L-ergothioneine is a physiologic cytoprotectant","volume":"17","author":"Paul","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2023.175759_bib28","first-page":"e2","article-title":"Heart disease and stroke statistics--2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.175759_bib29","first-page":"1","article-title":"Ergothioneine mitigates telomere shortening under oxidative stress conditions","volume":"Suppl","author":"Samuel","year":"2020","journal-title":"J. Diet"},{"key":"10.1016\/j.ejphar.2023.175759_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2014.11.017","article-title":"An uncommon redox behavior sheds light on the cellular antioxidant properties of ergothioneine","volume":"79","author":"Servillo","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2023.175759_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1247\/csf.26.25","article-title":"Structure and function of VEGF\/VEGF-receptor system involved in angiogenesis","volume":"26","author":"Shibuya","year":"2001","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.ejphar.2023.175759_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2217\/bmm.15.111","article-title":"Prognostic use of soluble fms-like tyrosine kinase-1 and placental growth factor in patients with coronary artery disease","volume":"10","author":"Sinning","year":"2016","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.ejphar.2023.175759_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/heartjnl-2019-315485","article-title":"Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease","volume":"106","author":"Smith","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2023.175759_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature10085","article-title":"Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells","volume":"474","author":"Stefater","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.175759_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2023.175759_bib36","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tcb.2012.08.001","article-title":"The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation","volume":"22","author":"Tornatore","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2023.175759_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/HYPERTENSIONAHA.119.13929","article-title":"L-(+)-Ergothioneine significantly improves the clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model","volume":"75","author":"Williamson","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2023.175759_bib38","doi-asserted-by":"crossref","DOI":"10.3791\/2464","article-title":"Acute myocardial infarction in rats","author":"Wu","year":"2011","journal-title":"J. Vis. Exp."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:21:58Z","timestamp":1762143718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923002704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"alternative-id":["S0014299923002704"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175759","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ergothioneine improves myocardial remodeling and heart function after acute myocardial infarction via S-glutathionylation through the NF-\u0138B dependent Wnt5a-sFlt-1 pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175759"}}